Quantum Surgical

Quantum Surgical is a company speacializing in medical robotics and AI. Its Epione® robotic percutaneous ablation platform is dedicated to the curative and early treatment of cancers. Quantum Surgical thus offers a new approach to cancer treatment by standardizing access to care. More patients can benefit from innovative, better targeted and less invasive treatments. More than 1,400 of patients have already been treated worldwide.

Co-founded in 2017 and with a team of 140+ employees, Quantum Surgical is headquarted in Miami, Florida, with offices in Montpellier, France. Quantum Surgical received the Prix Galien USA in 2022, the equivalent of the Nobel Prize for biopharmaceutical research and joined in 2023 the governmental French Tech 2030 program in 2023 that supports top emerging actors in disruptive innovation.

Quantum Surgical recently acquired NeuWave Medical. Together, the two companies now operate under the newly formed parent company, Precision IO Group, with the ambition to transform the standard of care in tumor ablation and interventional oncology through innovation.